Boots, Britain's Premier chemist chain, on Thursday reported only a 7.8 percent rise in annual pre tax profits at 694.5 million pounds Lrb 311.8 million dollars Rrb, after withdrawing its heart drug from the market and expensive restructuring costs.
Boots reports 7.8 percent rise in pre tax profits.